Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 14, 2007

View Archived Issues

Positive preclinical results with a combined hepatitis A and E vaccine

Active end to 2006 for Gilead Sciences

T-2000 improves essential tremor in two small studies

Safety and efficacy of a transdermal Alzheimer's Abeta/CT vaccine shown in mice

Promising preclinical results with Domantis domain antibodies against vaginal candidiasis

Lonafarnib to enter clinic for the treatment of progeria syndromes

SIR-Spheres, bevacizumab + chemotherapy studied for metastatic colorectal cancer

Wyeth welcomes decision to fund pneumococcal vaccine for developing countries

Recent patents cover therapeutic agents for cardiovascular disorders

Novel treatment options for HCV infection reported in recent patents

Recent Bayer and AiCuris patents disclose new antiinfective agents

GSK commends pneumococcal vaccine advance market commitment

PEP-005 Topical studied in phase II trial for superficial BCC

Cytyc to acquire Adeza

Micromet exercises option for Morphotek antibody

Ariad grants commercial license to Argent technology to CellNexus

Ambrx studies next-generation human growth hormone product in phase I/II study

Adolor studies novel delta opioid receptor agonists

Avant and Select Vaccines to develop improved viral vaccines

Fast track designation for BioThrax for anthrax post-exposure prophylaxis

Biovail to use Depomed's AcuForm technology

Findings made available from Diabetes Genetics Initiative

Revisions to U.S. prescribing information for Ketek

Interim data support improvements in inflammatory arthritis with tgAAC94

Ono updates recent developments

Accelerated reviews for maraviroc

Recent Pfizer patent discloses novel therapeutic agents for gastrointestinal disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...